Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene
Richard H. Duerr,1,2Kent D. Taylor,3,4Steven R. Brant,5,6John D. Rioux,7,8Mark S. Silverberg,9Mark J. Daly,8,10A. Hillary Steinhart,9Clara Abraham,11Miguel Regueiro,1Anne Griffiths,12Themistocles Dassopoulos,5Alain Bitton,13Huiying Yang,3,4Stephan Targan,4,14Lisa Wu Datta,5Emily O. Kistner,15L. Philip Schumm,15Annette T. Lee,16Peter K. Gregersen,16M. Michael Barmada,2Jerome I. Rotter,3,4Dan L. Nicolae,11,17Judy H. Cho18*
The inflammatory bowel diseases Crohn's disease and ulcerativecolitis are common, chronic disorders that cause abdominal pain,diarrhea, and gastrointestinal bleeding. To identify geneticfactors that might contribute to these disorders, we performeda genome-wide association study. We found a highly significantassociation between Crohn's disease and the IL23R gene on chromosome1p31, which encodes a subunit of the receptor for the proinflammatorycytokine interleukin-23. An uncommon coding variant (rs11209026,c.1142G>A, p.Arg381Gln) confers strong protection againstCrohn's disease, and additional noncoding IL23R variants areindependently associated. Replication studies confirmed IL23Rassociations in independent cohorts of patients with Crohn'sdisease or ulcerative colitis. These results and previous studieson the proinflammatory role of IL-23 prioritize this signalingpathway as a therapeutic target in inflammatory bowel disease.
1 Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, School of Medicine, University of Pittsburgh, University of Pittsburgh Medical Center Presbyterian, Mezzanine Level, C-Wing, 200 Lothrop Street, Pittsburgh, PA 15213, USA. 2 Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Crabtree A300, 130 Desoto Street, Pittsburgh, PA15261, USA. 3 Medical Genetics Institute, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA. 4 IBD Center, Division of Gastroenterology, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA. 5 Harvey M. and Lyn P. Meyerhoff Inflammatory Bowel Disease Center, Department of Medicine, Johns Hopkins University School of Medicine, B136, 1503 East Jefferson Street, Baltimore, MD 21231, USA. 6 Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, 615 North Wolfe Street, Baltimore, MD 21205, USA. 7 Université de Montréal and the Montreal Heart Institute, S-6400, 5000 Belanger Street, Montreal, Quebec H1T 1C8, Canada. 8 Medical and Population Genetics Program, Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, MA 02142, USA. 9 Mount Sinai Hospital IBD Centre, University of Toronto, 441600 University Avenue, Toronto, Ontario M5G 1X5, Canada. 10 Massachusetts General Hospital, Harvard Medical School, 185 Cambridge Street, Boston, MA 02114, USA. 11 Department of Medicine, University of Chicago, 5841 South Maryland Avenue, Chicago, IL 60637, USA. 12 Department of Pediatrics, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario M5G 1X8, Canada. 13 Royal Victoria Hospital, McGill University Health Centre, 687 Pine Avenue West, Montreal, Quebec H3A 1A1, Canada. 14 Immunobiology Research Institute, Cedars-Sinai Medical Center, Davis 4063, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA. 15 Department of Health Studies, University of Chicago, 5841 South Maryland Avenue, Chicago, IL 60637, USA. 16 The Feinstein Institute for Medical Research, 350 Community Drive, Manhasset, NY 11030, USA. 17 Department of Statistics, University of Chicago, 5734 South University Avenue, Chicago, IL 60637, USA. 18 IBD Center, Section of Digestive Diseases, Departments of Medicine and Genetics, Yale University, S155A, 300 Cedar Street, New Haven, CT 06519, USA.
* To whom correspondence should be addressed. E-mail: judy.cho{at}yale.edu
Genome-wide association scans identified CTNNBL1 as a novel gene for obesity.
Y.-J. Liu, X.-G. Liu, L. Wang, C. Dina, H. Yan, J.-F. Liu, S. Levy, C. J. Papasian, B. M. Drees, J. J. Hamilton, et al. (2008)
Hum. Mol. Genet.
17, 1803-1813
|Abstract »|Full Text »|PDF »
Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells.
F. Gerosa, B. Baldani-Guerra, L. A. Lyakh, G. Batoni, S. Esin, R. T. Winkler-Pickett, M. R. Consolaro, M. De Marchi, D. Giachino, A. Robbiano, et al. (2008)
J. Exp. Med.
205, 1447-1461
|Abstract »|Full Text »|PDF »
In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ ROR{gamma}t+ T cells.
M. Lochner, L. Peduto, M. Cherrier, S. Sawa, F. Langa, R. Varona, D. Riethmacher, M. Si-Tahar, J. P. Di Santo, and G. Eberl (2008)
J. Exp. Med.
205, 1381-1393
|Abstract »|Full Text »|PDF »
IL-27R deficiency delays the onset of colitis and protects from helminth-induced pathology in a model of chronic IBD.
A. V. Villarino, D. Artis, J. S. Bezbradica, O. Miller, C. J. M. Saris, S. Joyce, and C. A. Hunter (2008)
Int. Immunol.
20, 739-752
|Abstract »|Full Text »|PDF »
Interleukin promoter polymorphisms and prognosis in colorectal cancer.
S. Wilkening, B. Tavelin, F. Canzian, K. Enquist, R. Palmqvist, A. Altieri, G. Hallmans, K. Hemminki, P. Lenner, and A. Forsti (2008)
Carcinogenesis
29, 1202-1206
|Abstract »|Full Text »|PDF »
Impaired Bcl3 Up-regulation Leads to Enhanced Lipopolysaccharide-induced Interleukin (IL)-23P19 Gene Expression in IL-10-/- Mice.
M. Muhlbauer, P. M. Chilton, T. C. Mitchell, and C. Jobin (2008)
J. Biol. Chem.
283, 14182-14189
|Abstract »|Full Text »|PDF »
The complex genetics of multiple sclerosis: pitfalls and prospects.
Interleukin (IL)-23 Receptor Is a Major Susceptibility Gene for Graves' Ophthalmopathy: The IL-23/T-helper 17 Axis Extends to Thyroid Autoimmunity.
A. K. Huber, E. M. Jacobson, K. Jazdzewski, E. S. Concepcion, and Y. Tomer (2008)
J. Clin. Endocrinol. Metab.
93, 1077-1081
|Abstract »|Full Text »|PDF »
Thiopurine Drugs Azathioprine and 6-Mercaptopurine Inhibit Mycobacterium paratuberculosis Growth In Vitro.
S. J. Shin and M. T. Collins (2008)
Antimicrob. Agents Chemother.
52, 418-426
|Abstract »|Full Text »|PDF »
The Myeloid Differentiation Factor 88 (MyD88) Is Required for CD4+ T Cell Effector Function in a Murine Model of Inflammatory Bowel Disease.
M. Fukata, K. Breglio, A. Chen, A. S. Vamadevan, T. Goo, D. Hsu, D. Conduah, R. Xu, and M. T. Abreu (2008)
J. Immunol.
180, 1886-1894
|Abstract »|Full Text »|PDF »
Functional variants of interleukin-23 receptor gene confer risk for rheumatoid arthritis but not for systemic sclerosis.
B Farago, L Magyari, E Safrany, V Csongei, L Jaromi, K Horvatovich, C Sipeky, A Maasz, J Radics, A Gyetvai, et al. (2008)
Ann Rheum Dis
67, 248-250
|Abstract »|Full Text »|PDF »
Breakthroughs in genetic studies of ankylosing spondylitis.
Commensal Gut Flora Drives the Expansion of Proinflammatory CD4 T Cells in the Colonic Lamina Propria under Normal and Inflammatory Conditions.
J. H. Niess, F. Leithauser, G. Adler, and J. Reimann (2008)
J. Immunol.
180, 559-568
|Abstract »|Full Text »|PDF »
Gender-stratified analysis of DLG5 R30Q in 4707 patients with Crohn disease and 4973 controls from 12 Caucasian cohorts.
B L Browning, V Annese, M L Barclay, S A Bingham, S Brand, C Buning, M Castro, S Cucchiara, B Dallapiccola, H Drummond, et al. (2008)
J. Med. Genet.
45, 36-42
|Abstract »|Full Text »|PDF »
Cytokines in arthritis the 'big numbers' move centre stage.
An insertion deletion polymorphism in the Interferon Regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases.
V. Dideberg, G. Kristjansdottir, L. Milani, C. Libioulle, S. Sigurdsson, E. Louis, A.-C. Wiman, S. Vermeire, P. Rutgeerts, J. Belaiche, et al. (2007)
Hum. Mol. Genet.
16, 3008-3016
|Abstract »|Full Text »|PDF »
IL-23 Is Required for Neutrophil Homeostasis in Normal and Neutrophilic Mice.
E. Smith, A. Zarbock, M. A. Stark, T. L. Burcin, A. C. Bruce, P. Foley, and K. Ley (2007)
J. Immunol.
179, 8274-8279
|Abstract »|Full Text »|PDF »
A forest-based approach to identifying gene and gene gene interactions.
Genome-Wide Association: Which Do You Want First: the Good News, the Bad News, or the Good News?.
K. D. Taylor, J. M. Norris, and J. I. Rotter (2007)
Diabetes
56, 2844-2848
|Full Text »|PDF »
Expression of IL-12-related molecules in human intestinal microvascular endothelial cells is regulated by TLR3.
J. Heidemann, C. Ruther, M. Kebschull, W. Domschke, M. Bruwer, S. Koch, T. Kucharzik, and C. Maaser (2007)
Am J Physiol Gastrointest Liver Physiol
293, G1315-G1324
|Abstract »|Full Text »|PDF »
Allelic variant in CTLA4 alters T cell phosphorylation patterns.
L. M. Maier, D. E. Anderson, P. L. De Jager, L. S. Wicker, and D. A. Hafler (2007)
PNAS
104, 18607-18612
|Abstract »|Full Text »|PDF »
Future Use of Genomics in Coronary Artery Disease.
Mycobacterium paratuberculosis is recognized by Toll-like receptors and NOD2.
G. Ferwerda, B. J. Kullberg, D. J. de Jong, S. E. Girardin, D. M. L. Langenberg, R. van Crevel, T. H. M. Ottenhoff, J. W. M. Van der Meer, and M. G. Netea (2007)
J. Leukoc. Biol.
82, 1011-1018
|Abstract »|Full Text »|PDF »
Genetic Susceptibility to Peripheral Arterial Disease: A Dark Corner in Vascular Biology.
J. W. Knowles, T. L. Assimes, J. Li, T. Quertermous, and J. P. Cooke (2007)
Arterioscler. Thromb. Vasc. Biol.
27, 2068-2078
|Abstract »|Full Text »|PDF »
TRAF1-C5 as a Risk Locus for Rheumatoid Arthritis -- A Genomewide Study.
R. M. Plenge, M. Seielstad, L. Padyukov, A. T. Lee, E. F. Remmers, B. Ding, A. Liew, H. Khalili, A. Chandrasekaran, L. R.L. Davies, et al. (2007)
N. Engl. J. Med.
357, 1199-1209
|Abstract »|Full Text »|PDF »
Investigation of NOD1/CARD4 variation in inflammatory bowel disease using a haplotype-tagging strategy.
J. Van Limbergen, E. R. Nimmo, R. K. Russell, H. E. Drummond, L. Smith, N. H. Anderson, G. Davies, I. D. Arnott, D. C. Wilson, and J. Satsangi (2007)
Hum. Mol. Genet.
16, 2175-2186
|Abstract »|Full Text »|PDF »
From the Cover: Genome-wide association study for Crohn's disease in the Quebec Founder Population identifies multiple validated disease loci.
J. V. Raelson, R. D. Little, A. Ruether, H. Fournier, B. Paquin, P. Van Eerdewegh, W. E. C. Bradley, P. Croteau, Q. Nguyen-Huu, J. Segal, et al. (2007)
PNAS
104, 14747-14752
|Abstract »|Full Text »|PDF »
STAT4 and the Risk of Rheumatoid Arthritis and Systemic Lupus Erythematosus.
E. F. Remmers, R. M. Plenge, A. T. Lee, R. R. Graham, G. Hom, T. W. Behrens, P. I.W. de Bakker, J. M. Le, H.-S. Lee, F. Batliwalla, et al. (2007)
N. Engl. J. Med.
357, 977-986
|Abstract »|Full Text »|PDF »
Recent Advances in the Genetics of Autoimmune Diseases.
Association of the T300A non-synonymous variant of the ATG16L1 gene with susceptibility to paediatric Crohn's disease.
R. N Baldassano, J. P Bradfield, D. S Monos, C. E Kim, J. T Glessner, T. Casalunovo, E. C Frackelton, F G. Otieno, S. Kanterakis, J. L Shaner, et al. (2007)
Gut
56, 1171-1173
|Full Text »|PDF »
IL23R Arg381Gln is associated with childhood onset inflammatory bowel disease in Scotland.
J Van Limbergen, %R K Russell, E R Nimmo, H E Drummond, L Smith, G Davies, N H Anderson, P M Gillett, P McGrogan, K Hassan, et al. (2007)
Gut
56, 1173-1174
|Full Text »|PDF »
Genetic Susceptibility, HIV Infection, and the Kidney.
K. Kiryluk, J. Martino, and A. G. Gharavi (2007)
Clin. J. Am. Soc. Nephrol.
2, S25-S35
|Abstract »|Full Text »|PDF »
Inhibitory Effect of Enterohepatic Helicobacter hepaticus on Innate Immune Responses of Mouse Intestinal Epithelial Cells.
T. Sterzenbach, S. K. Lee, B. Brenneke, F. von Goetz, D. B. Schauer, J. G. Fox, S. Suerbaum, and C. Josenhans (2007)
Infect. Immun.
75, 2717-2728
|Abstract »|Full Text »|PDF »
Genome-Wide Association Analysis Identifies Loci for Type 2 Diabetes and Triglyceride Levels.
Diabetes Genetics Initiative of Broad Institute of, R. Saxena, B. F. Voight, V. Lyssenko, N. P. Burtt, P. I. W. de Bakker, H. Chen, J. J. Roix, S. Kathiresan, J. N. Hirschhorn, et al. (2007)
Science
316, 1331-1336
|Abstract »|Full Text »|PDF »
Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus.
R. R. Graham, C. Kyogoku, S. Sigurdsson, I. A. Vlasova, L. R. L. Davies, E. C. Baechler, R. M. Plenge, T. Koeuth, W. A. Ortmann, G. Hom, et al. (2007)
PNAS
104, 6758-6763
|Abstract »|Full Text »|PDF »
Modern Genetics, Ancient Defenses, and Potential Therapies.
P. K. Gregersen (2007)
N. Engl. J. Med.
356, 1263-1266
|Full Text »|PDF »
Rapid Dissection of the Genetic Risk of Age-Related Macular Degeneration: Achieving the Promise of the Genomic Era.
J. L. Haines and M. A. Pericak-Vance (2007)
JAMA
297, 401-402
|Full Text »|PDF »